Navigation Links
eCardio Launches NEW Atrial Fibrillation Information System (AFIS(TM))
Date:5/15/2009

First Comprehensive Software Application to Offer Single Platform for AF Patient Management

BOSTON, May 15 /PRNewswire/ -- eCardio Diagnostics (www.ecardio.com) announced the launch of its NEW Atrial Fibrillation Information System (AFIS(TM)) today at Heart Rhythm 2009, the Annual Scientific Sessions of the Heart Rhythm Society. AFIS(TM) is an informatics solution that presents a longitudinal view of atrial fibrillation and tachyarrhythmic patients for teaching, research or clinical management. It is the first comprehensive software application to gather all associated clinical information in one place for AF patient management.

"Managing patients with atrial fibrillation is a daunting task, requiring the physician to evaluate numerous data sources, such as films, sonogram images and ECG reports," noted Nassir Marrouche, MD, Director of the Atrial Fibrillation Program at the University of Utah School of Medicine. "We developed AFIS(TM) to provide a single-platform application that not only gathers relevant clinical information in one place, but also provides a number of analytical tools to enable doctors to provide the best care for our patients."

Designed specifically to meet the needs of electrophysiologists in academic medicine, AFIS(TM) captures imaging, monitoring, procedural reports, clinic notes and patient history to provide clinicians with the most longitudinal data set on which to render treatment decisions. AFIS(TM) provides multi-factorial analysis tools for:

  • Data mining for clinical research;
  • Participation in the first international AF Registry;
  • Calculation of left atrial scar; and
  • Clinical management of the AF patient.

AFIS(TM) has been developed in collaboration with the University of Utah School of Medicine and is overseen by the Atrial Fibrillation Physician Advisory Board whose members include:

  • Nassir Marrouche, MD, Chair, Director of the Atrial Fibrillation Program, University of Utah School of Medicine
  • Oussama Wazni, MD, Electrophysiology Lab Director, Cleveland Clinic Foundation
  • Kalyanam Shivkumar, MD, PhD, Director of the Cardiac Arrhythmia Center, UCLA School of Medicine
  • Edward Gerstenfeld, MD, Cardiovascular Division, University of Pennsylvania School of Medicine
  • Professor Dr. Johannes Brachmann, MD, Chief of Cardiology, Med Klinik Klinikum Coburg
  • Nathan Segerson, MD, Kitsap Cardiology Consultants

AFIS(TM) will be installed at a select number of institutions in 2009 and will be available at additional centers next year.

About eCardio Diagnostics

eCardio Diagnostics, www.ecardio.com, is the nation's leading provider of comprehensive and advanced technologies, devices, services and solutions for the diagnosis, monitoring and subsequent clinical management of cardiac arrhythmias, predominantly in the ambulatory setting. eCardio provides leading-edge diagnostic innovations and solutions that optimize the flexibility, speed and accuracy of cardiac arrhythmia diagnoses--contributing to the timeliest, most effective and appropriate management of cardiac patients.


'/>"/>
SOURCE eCardio Diagnostics
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. eCardio Diagnostics Launches Academic Medicine Initiative
2. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
3. UPMC Health Plan Launches New Personal Health Record
4. HealthInsuranceFinders.com Launches Video Contest for Young Directors
5. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
6. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
7. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
8. Mannatech Launches Phase One of New Sales and Training Tools
9. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
10. Actavis Launches Carvedilol Tablets in the U.S.
11. MedQuist Re-launches New, Improved Web Site
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... 2017 , ... East Los Angeles dentist, Ramin Assili DDS , comments ... happens to a woman during pregnancy can have profound effects on a developing fetus, ... on a baby’s long-term health. This study, which was performed at the University of ...
(Date:6/26/2017)... Torrance, CA (PRWEB) , ... June 26, 2017 , ... ... treatments. Smile aesthetics can be one of the most noticeable aspects of a person’s ... approachable. While not everyone is born with beautiful, balanced teeth, everyone can have the ...
(Date:6/26/2017)... ... June 26, 2017 , ... ... & Sexual Medicine Specialists, in collaboration with the Fertility Center of California, is ... care: PESA (percutaneous epidydimal sperm aspiration) and TESA (percutaneous testicular sperm extraction). These ...
(Date:6/26/2017)... SALISBURY, MD. (PRWEB) , ... June 26, 2017 ... ... their crop, according to a recent review of government data released by the ... continuous improvement in management practices, Maryland’s soybean farmers have increased their productivity on ...
(Date:6/26/2017)... Lake Tahoe, CA (PRWEB) , ... June 26, 2017 , ... ... seeking 10,000 qualified mental health professionals in every state across the country to join ... an easy and rewarding way for therapists to reach a substantially greater number of ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... -- Less than a month ago, amateur hackers executed an ... hospital networks, in over 150 countries. The ... online extortion attempts ever recorded. With the increasing complexity ... that providers understand where the risks lie, and how ... many other very real cyber threats.  ...
(Date:6/7/2017)... GAITHERSBURG, Md. , June 7, 2017  Novavax, Inc., ... the second of two Phase 2 trials of its RSV ... women of child bearing age have been published in the ... this publication have been shared in prior scientific conferences). The ... trial in April 2014. Novavax is developing the RSV F ...
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
Breaking Medicine Technology: